ACM
MDT icon

AlphaStar Capital Management’s Medtronic MDT Stock Holding History

AlphaStar Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,207
Closed -$725K – 232
2020
Q4 		$725K Buy
+6,207
New +$683K 0.12% 113
2020
Q1 		– Sell
-4,415
Closed -$501K – 213
2019
Q4 		$501K Buy
4,415
+1,018
+30% +$112K 0.11% 120
2019
Q3 		$369K Buy
3,397
+135
+4% +$14.1K 0.09% 142
2019
Q2 		$318K Buy
+3,262
New +$298K 0.08% 167
2017
Q4 		– Sell
-3,248
Closed -$253K – 206
2017
Q3 		$253K Buy
+3,248
New +$270K 0.25% 79

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaStar Capital Management's MDT Position: Q1 2021 in Review

AlphaStar Capital Management sold out of Medtronic (MDT) in Q1 2021, closing a stake of 6,207 shares — an estimated $725K sold.

AlphaStar Capital Management first reported a position in MDT in Q3 2017 and held it in 5 quarters. The position peaked at $725K in Q4 2020. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • AlphaStar Capital Management reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
  • AlphaStar Capital Management sold 6,207 Medtronic shares in Q1 2021, an estimated $725K.
  • AlphaStar Capital Management first reported a position in Medtronic in Q3 2017 and held it in 5 quarters.
  • AlphaStar Capital Management's Medtronic position peaked at $725K in Q4 2020.
  • 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on AlphaStar Capital Management's 13F filing for Q1 2021, filed 3 May 2021.